Janney Montgomery Scott LLC Harrow Health, Inc. Transaction History

Janney Montgomery Scott LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$6.57 - $24.88 $315 - $1,194	-48 Reduced 0.45%	10,624 $128,000
Q2 2022 Aug 03, 2022	SELL	$5.75 - $7.74 $7,532 - $10,139	-1,310 Reduced 10.93%	10,672 $78,000
Q1 2022 May 04, 2022	BUY	$6.77 - $8.66 $406 - $519	60 Added 0.5%	11,982 $82,000
Q4 2021 Jan 27, 2022	SELL	$8.5 - $12.0 $3,859 - $5,448	-454 Reduced 3.67%	11,922 $103,000
Q3 2021 Oct 29, 2021	SELL	$6.99 - $10.6 $692 - $1,049	-99 Reduced 0.79%	12,376 $112,000
Q2 2021 Jul 26, 2021	SELL	$6.68 - $11.07 $1,937 - $3,210	-290 Reduced 2.27%	12,475 $116,000
Q1 2021 Apr 27, 2021	BUY	$6.26 - $11.03 $79,908 - $140,797	12,765 New	12,765 $86,000

175

21.2M

844K

698K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $839M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.